SLEEP AND MENTAL HEALTH: THE RELATIONSHIP BETWEEN SLEEP DISORDERS AND DEPRESSION
Abstract
Sleep disturbances are a core feature of depressive disorders, occurring in most patients during both acute episodes and remission. Insomnia is the most prevalent form and significantly affects treatment response and relapse risk. The relationship between sleep and depression is bidirectional—sleep problems may precede, co-occur with, or result from depression. Non-pharmacological approaches such as cognitive behavioral therapy for insomnia (CBT-I) have proven effective in improving both sleep quality and depressive symptoms, especially when combined with antidepressants. Somatic interventions like chronotherapy, light therapy and sleep cycle manipulation also show promising outcomes. Recognizing and treating sleep disturbances as a primary therapeutic target can enhance the overall effectiveness of depression management and support long-term remission.
References
Luca A, et al. Sleep disorders and depression: brief review of the literature, case report, and nonpharmacologic interventions for depression. Clin Interv Aging, 2013 Aug 5;8:1033–1039. doi: 10.2147/CIA.S47230.
Manber R, et al. Cognitive Behavioral Therapy for Insomnia Enhances Depression Outcome in Patients with Comorbid Major Depressive Disorder and Insomnia. Sleep. 2008 Apr;31(4):489-95. doi: 10.1093/sleep/31.4.489.
Yasugaki S, et al. Bidirectional relationship between sleep and depression. Neurosci Res.2025 Feb:211:57-64. doi: 10.1016/j.neures.2023.04.006.
Takahashi, Y., Kipnis, D.M., Daughaday, W.H., 1968. Growth hormone secretion during sleep. J. Clin. Investig. 47 (9), 2079–2090. https://doi.org/10.1172/JCI105893.
Chauvette, S., Seigneur, J., Timofeev, I., 2012. Sleep oscillations in the thalamocortical system induce long-term neuronal plasticity. Neuron 75 (6), 1105–1113. https://doi.org/10.1016/j.neuron.2012.08.034.
Xie, L., et al., 2013. Sleep drives metabolite clearance from the adult brain. Science 342 (6156), 373–377. https://doi.org/10.1126/science.1241224.
Tsai, C.-J., et al., 2021. Cerebral capillary blood flow upsurge during REM sleep is mediated by A2a receptors. In: Cell reports, 36. Elsevier, 109558. https://doi.org/10.1016/j.celrep.2021.109558.
Leproult, R., et al., 1997. Sleep loss results in an elevation of cortisol levels the next evening. Sleep 20 (10), 865–870 (Available at). 〈https://www.ncbi.nlm.nih.gov/pubmed/9415946〉.
Reynolds 3rd, C.F., Kupfer, D.J., 1987. Sleep research in affective illness: state of the art circa 1987. Sleep 10 (3), 199–215. https://doi.org/10.1093/sleep/10.3.199.
Borb´ ely, A.A., et al., 1984. All-night spectral analysis of the sleep EEG in untreated depressives and normal controls. Psychiatry Res. 12 (1), 27–33. https://doi.org/10.1016/0165-1781(84)90135-5.
Buysse, D.J., et al., 1997. Electroencephalographic sleep correlates of episode and vulnerability to recurrence in depression. Biol. Psychiatry 41 (4), 406–418. https://doi.org/10.1016/S0006-3223(96)00041-8.
Reynolds 3rd, C.F., et al., 1985. EEG sleep in elderly depressed, demented, and healthy subjects. In: Biological psychiatry, 20. Elsevier, pp. 431–442. https://doi.org/10.1016/0006-3223(85)90045-9.
Kupfer, D.J., Foster, F.G., 1972. Interval between onset of sleep and rapid-eye-movement sleep as an indicator of depression. Lancet 2 (7779), 684–686. https://doi.org/10.1016/s0140-6736(72)92090-9.
Pillai, V., Kalmbach, D.A., Ciesla, J.A., 2011. A meta-analysis of electroencephalographic sleep in depression: evidence for genetic biomarkers. Biol. Psychiatry 70 (10), 912–919. https://doi.org/10.1016/j.biopsych.2011.07.016.
Wang, Y.-Q., et al., 2015. The neurobiological mechanisms and treatments of REM sleep disturbances in depression. Curr. Neuropharmacol. 13 (4), 543–553. https://doi.org/10.2174/1570159x13666150310002540.
Riemann, D., et al., 2020. Sleep, insomnia, and depression. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 45 (1), 74–89. https://doi.org/10.1038/s41386-019-0411-y.
Giles, D.E., et al., 1987. Reduced rapid eye movement latency. A predictor of recurrence in depression. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 1 (1), 33–39. https://doi.org/10.1016/0893-133x(87)90007-8.
Steiger, A., Kimura, M., 2010. Wake and sleep EEG provide biomarkers in depression. In: Journal of psychiatric research, 44. Elsevier, pp. 242–252. https://doi.org/10.1016/j.jpsychires.2009.08.013.
Wichniak, A., Wierzbicka, A., Jernajczyk, W., 2013. Sleep as a biomarker for depression. Int. Rev. Psychiatry 25 (5), 632–645. https://doi.org/10.3109/09540261.2013.812067.
Buysse, D.J., et al., 2008. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep 31 (4), 473–480. https://doi.org/10.1093/sleep/31.4.473.
Jaussent, I., et al., 2011. Insomnia and daytime sleepiness are risk factors for depressive symptoms in the elderly. Sleep 34 (8), 1103–1110. https://doi.org/10.5665/SLEEP.1170.
Weissman, M.M., et al., 1997. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen. Hosp. Psychiatry 19 (4), 245–250. https://doi.org/10.1016/s0163-8343(97)00056-x.
Ong SH, Wickramaratne P, Tang M, Weissman MM. Early childhood sleep and eating problems as predictors of adolescent and adult mood and anxiety disorders. J Affect Disord. 2006;96:1–8. doi: 10.1016/j.jad.2006.05.025.
Li SX, Lam SP, Chan JW, Yu MW, Wing YK. Residual sleep disturbances in patients remitted from major depressive disorder: a 4-year naturalistic follow-up study. Sleep. 2012;35:1153–1161. doi: 10.5665/sleep.2008.
Jindal RD, Thase ME. Treatment of insomnia associated with clinical depression. Sleep Med Rev. 2004;8:19–30. doi: 10.1016/S1087-0792(03)00025-X
Breslau, N., et al., 1996. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol. Psychiatry 39 (6), 411–418. https://doi.org/10.1016/0006-3223(95)00188-3.
Chang, P.P., et al., 1997. Insomnia in young men and subsequent depression: the Johns Hopkins Precursors Study. Am. J. Epidemiol. 146 (2), 105–114. https://doi.org/10.1093/oxfordjournals.aje.a009241.
Perlis, M.L., et al., 1997. Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J. Affect. Disord. 42 (2–3), 209–212. https://doi.org/10.1016/S0165-0327(96)01411-5.
Roberts, R.E., et al., 2000. Sleep complaints and depression in an aging cohort: a prospective perspective. Am. J. Psychiatry 157 (1), 81–88. https://doi.org/10.1176/ajp.157.1.81.
Buysse DJ, Reynolds CF, 3rd, Houck PR, et al. Does lorazepam impair the antidepressant response to nortriptyline and psychotherapy? J Clin Psychiatry. 1997;58:426–32. doi: 10.4088/jcp.v58n1003.
Dew MA, Reynolds CF, Houck PR, et al. Temporal profiles of the course of depression during treatment. Predictors of pathways toward recovery in the elderly. Arch Gen Psychiatry. 1997;54:1016–24. doi: 10.1001/archpsyc.1997.01830230050007.
3.Winokur A, Reynolds CF. The effects of antidepressants and anxiolitics on sleep physiology. Prim Psychiatry. 1994;1:22–7.
Thase ME, Buysse DJ, Frank E, et al. Which depressed patients will respond to interpersonal psychotherapy? The role of abnormal EEG sleep profiles. Am J Psychiatry. 1997;154:502–9. doi: 10.1176/ajp.154.4.502.
Thase ME. Depression, sleep, and antidepressants. J Clin Psychiatry. 1998;59:55–65.
Santos Moraes WA, Burke PR, Coutinho PL, et al. Sedative antidepressants and insomnia. Rev Bras Psiquiatr. 2011;33:91–95. doi: 10.1590/s1516-44462011000100017.
Kupfer, D.J., 1976. REM latency: a psychobiologic marker for primary depressive disease. Biol. Psychiatry 11 (2), 159–174 (Available at). https://www.ncbi.nlm.nih.gov/pubmed/183839
Kupfer DJ, Spiker DG. Nortriptyline and EEG sleep in depressed patients. Biol Psychiatry. 1982;17:535–546.
Sharpley AL, Cowen PJ. Effect of pharmacological treatments of depressed patients. Biol Psychiatry. 1995;37:85–98. doi: 10.1016/0006-3223(94)00135-P.
McCarley RW, Hobson JA. Neuronal excitability modulation over the sleep cycle: a structural and mathematical model. Science. 1975;189:58–60. doi: 10.1126/science.1135627.
San, L., Arranz, B., 2008. Agomelatine: a novel mechanism of antidepressant action involving the melatonergic and the serotonergic system. Eur. Psychiatry. J. Assoc. Eur. Psychiatr. 23 (6), 396–402. https://doi.org/10.1016/j.eurpsy.2008.04.002.
Quera Salva, M.-A., et al., 2007. Major depressive disorder, sleep EEG and agomelatine: an open-label study. Int. J. Neuropsychopharmacol. / Off. Sci. J. Coll. Int. Neuropsychopharmacol. 10 (5), 691–696. https://doi.org/10.1017/S1461145707007754.
Lˆoo, H., Hale, A., D’haenen, H., 2002. Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study. Int. Clin. Psychopharmacol. 17 (5), 239–247. https://doi.org/10.1097/00004850-200209000-00004.
Liu, R., et al., 2021. Contribution of DNA methyltransferases to spared nerve injury induced depression partially through epigenetically repressing Bdnf in hippocampus: reversal by ketamine. Pharmacol., Biochem., Behav. 200, 173079 https://doi.org/10.1016/j.pbb.2020.173079.
Duncan, W.C., et al., 2013. Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder. Int. J. Neuropsychopharmacol. / Off. Sci. J. Coll. Int. Neuropsychopharmacol. 16 (2), 301–311. https://doi.org/10.1017/S1461145712000545.
Duncan Jr, W.C., et al., 2017. Motor-activity markers of circadian timekeeping are related to ketamine’s rapid antidepressant properties. Biol. Psychiatry 82 (5), 361–369. https://doi.org/10.1016/j.biopsych.2017.03.011.
DiazGranados, N., et al., 2010. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J. Clin. Psychiatry 71 (12), 1605–1611. https://doi.org/10.4088/JCP.09m05327blu.
Daly, E.J., et al., 2018. Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial. JAMA Psychiatry 75 (2), 139–148. https://doi.org/10.1001/jamapsychiatry.2017.3739.
Corriger, A., Pickering, G., 2019. Ketamine and depression: a narrative review. Drug Des., Dev. Ther. 13, 3051–3067. https://doi.org/10.2147/DDDT.S221437.
American Academy of Sleep Medicine . The International Classification of Sleep Disorders. Rochester, MN: Allen Press; 1997.
Gureje O, Kola L, Ademola A, Olley BO. Profile, comorbidity and impact of insomnia in the Ibadan Study of Ageing. Int J Geriatr Psychiatry. 2009;24:686–693. doi: 10.1002/gps.2180.
Winokur A, Gary KA, Rodner S, Rae-Red C, Fernando AT, Szuba MP. Depression, sleep physiology, and antidepressant drugs. Depress Anxiety. 2001;14:19–28. doi: 10.1002/da.1043.
Benazzi F. Symptoms of depression as possible markers of bipolar II disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:471–477. doi: 10.1016/j.pnpbp.2005.11.016.
Kaplan KA, Harvey AG. Hypersomnia across mood disorders: a review and synthesis. Sleep Med Rev. 2009;13:275–285. doi: 10.1016/j.smrv.2008.09.001.
Kaplan KA, Gruber J, Eidelman P, Talbot LS, Harvey AG. Hypersomnia in inter-episode bipolar disorder: does it have prognostic significance? J Affect Disord. 2011;132:438–444. doi: 10.1016/j.jad.2011.03.013. 1 art 40
Matza LS, Revicki DA, Davidson JR, Stewart JW. Depression with atypical features in the national comorbidity survey: classification, description, and consequences. Arch Gen Psychiatry. 2003;60:817–826. doi: 10.1001/archpsyc.60.8.817.
Posternak MA, Zimmerman M. Symptoms of atypical depression. Psychiatry Res. 2001;104:175–181. doi: 10.1016/s0165-1781(01)00301-8.
American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
American Academy of Sleep Medicine . The International Classification of Sleep Disorders. Rochester, MN: Allen Press; 1997.
Klink M, Quan S. Prevalence of reported sleep disturbances in a general population and their relation to obstructive airway disease. Chest. 1987;91:540–546. doi: 10.1378/chest.91.4.540.
Ohayon MM, Morselli PL, Guilleminault C. Prevalence of nightmares and their relationship to psychopathology and daytime functioning in insomnia subjects. Sleep. 1997;20:340–348. doi: 10.1093/sleep/20.5.340.
Hartman D, Crisp AH, Sedgwick P, Borrow S. Is there a dissociative process in sleepwalking and night terrors? Postgrad Med J. 2001;77:244–249. doi: 10.1136/pmj.77.906.244.
Crisp AH, Matthews BM, Oakey M, Crutchfield M. Sleepwalking, night terrors, and consciousness. BMJ. 1990;300:360–362. doi: 10.1136/bmj.300.6721.360.
Llorente MD, Currier MB, Norman SE, Mellman TA. Night terrors in adults: phenomenology and relationship to psychopathology. J Clin Psychiatry. 1992;53:392–394.
Wirz-Justice A. Temporal organization as a therapeutic target. Dialogues Clin Neurosci. 2012;14:335–337. doi: 10.31887/DCNS.2012.14.4/awjustice.
Magnusson A, Partonen T. The diagnosis, symptomatology, and epidemiology of seasonal affective disorder. CNS Spectr. 2005;10:625–634. doi: 10.1017/s1092852900019593.
Epperson CN, Terman M, Terman JS, et al. Randomized clinical trial of bright light therapy for antepartum depression: preliminary findings. J Clin Psychiatry. 2004;65:421–425. doi: 10.4088/jcp.v65n0319.
Krysta K, Krzystanek M, Janas-Kozik M, Krupka-Matuszczyk I. Bright light therapy in the treatment of childhood and adolescence depression, antepartum depression, and eating disorders. J Neural Transm. 2012;119:1167–1172. doi: 10.1007/s00702-012-0863-2.
Buysse DJ. Insomnia. JAMA. 2013;20309:706–716. doi: 10.1001/jama.2013.193.
Tuunainen A, Kripke DF, Endo T. Light therapy for non-seasonal depression. Cochrane Database Syst Rev. 2004;2:CD004050. doi: 10.1002/14651858.CD004050.pub2.
Pflug, B., Tolle, ¨ R., 1971. Therapy of endogenous depressions using sleep deprivation. Practical and theoretical consequences. Der Nervenarzt 42 (3), 117–124 (Available at). 〈https://www.ncbi.nlm.nih.gov/pubmed/5550102〉
Boland, E.M., et al., 2017. Meta-analysis of the antidepressant effects of acute sleep deprivation. J. Clin. Psychiatry 78 (8), e1020–e1034. https://doi.org/10.4088/JCP.16r11332
Berger M, van Calker D, Riemann D. Sleep and manipulations of the sleep-wake rhythm in depression. Acta Psychiatr Scand Suppl. 2003;418:83–91. doi: 10.1034/j.1600-0447.108.s418.17.x.
Gerner, R.H., et al., 1979. Biological and behavioral effects of one night’s sleep deprivation in depressed patients and normals. J. Psychiatr. Res. 15 (1), 21–40. https://doi.org/10.1016/0022-3956(79)90004-9.
51.Benedetti F, Barbini B, Campori E, Fulgosi MC, Pontiggia A, Colombo C. Sleep phase advance and lithium to sustain the antidepressant effect of total sleep deprivation in bipolar depression: new findings supporting the internal coincidence model? J Psychiatr Res. 2001;35:323–329. doi: 10.1016/s0022-3956(01)00034-6.
Bouhuys AL. Towards a model of mood responses to sleep deprivation in depressed patients. Biol Psychiatry. 1991;29:600–612. doi: 10.1016/0006-3223(91)90095-4.
Vogel, G.W., et al., 1973. The effect of REM deprivation on depression. Psychosomatics 14 (2), 104–107. https://doi.org/10.1016/S0033-3182(73)71363-3.
Vogel, G.W., 1975. A review of REM sleep deprivation. Arch. Gen. Psychiatry 32 (6), 749–761. https://doi.org/10.1001/archpsyc.1975.01760240077006.
Riemann, D., et al., 2012. REM sleep instability–a new pathway for insomnia? Pharmacopsychiatry 45 (5), 167–176. https://doi.org/10.1055/s-0031-1299721.
Wassing, R., et al., 2016. Slow dissolving of emotional distress contributes to hyperarousal. Proc. Natl. Acad. Sci. USA 113 (9), 2538–2543. https://doi.org/10.1073/pnas.1522520113.
Taylor, D.J., Pruiksma, K.E., 2014. Cognitive and behavioural therapy for insomnia (CBT-I) in psychiatric populations: a systematic review. In: International review of psychiatry, 26. Taylor & Francis, pp. 205–213. https://doi.org/10.3109/009540261.2014.902808.
Morin C, Culbert J, Schwartz S. Nonpharmacological interventions for insomnia: A meta-analysis of treatment efficacy. Am J Psychiatry. 1994;151:1172–80. doi: 10.1176/ajp.151.8.1172
Murtagh D, Greenwood K. Identifying effective psychological treatments for insomnia: A meta-analysis. J Consult Clin Psychol. 1995;63:79–89. doi: 10.1037//0022-006x.63.1.79.
Nowell P, Mazumdar S, Buysse D, Dew M, Reynolds CF, Kupfer D. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA. 1997;278:2170–7.
Smith MT, Perlis ML, Park A, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry. 2002;159:5–11. doi: 10.1176/appi.ajp.159.1.5.
Morin CM, Colecchi C, Stone J, Sood RM. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA. 1999;281:991–9. doi: 10.1001/jama.281.11.991.
Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE. Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial. JAMA. 2001;285:1856–1864. doi: 10.1001/jama.285.14.1856.
Lichstein KL, Wilson NM, Johnson CT. Psychological treatment of secondary insomnia. Psychol Aging. 2000;15:232–240. doi: 10.1037//0882-7974.15.2.232.
Perlis MM, Aloia M, Millikan, A, et al. Behavioral treatment of insomnia: a clinical case series study. J Behav Med. 1999;23:149–161. doi: 10.1023/a:1005413117932.
Kuo T, Manber R, Loewy D. Insomniacs with comorbid conditions achieved comparable improvement in a cognitive behavioral group treatment program as insomniacs without comorbid depression. Sleep. 2001;14:A62.
Taylor DJ, Lichstein KL, Weinstock J, Sanford S, Temple JR. A pilot study of cognitive-behavioral therapy of insomnia in people with mild depression. Behav Ther. 2007;38:49–57. doi: 10.1016/j.beth.2006.04.002.
Smith, M.T., Huang, M.I., Manber, R., 2005. Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders. In: Clinical psychology review, 25. Elsevier, pp. 559–592. https://doi.org/10.1016/j.cpr.2005.04.004.
Franzen, P.L., Buysse, D.J., 2008. Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. In: Dialogues in clinical neuroscience, 10. Informa UK Limited, pp. 473–481. https://doi.org/10.31887/dcns.2008.10.4/plfranzen.
Cunningham, J.E.A., Shapiro, C.M., 2018. Cognitive behavioural therapy for insomnia (CBT-I) to treat depression: a systematic review. J. Psychosom. Res. 106, 1–12. https://doi.org/10.1016/j.jpsychores.2017.12.012.
Perlis ML, Smith LJ, Lyness JM, et al. Insomnia as a risk factor for onset of depression in the elderly. Behav Sleep Med. 2006;4:104–13. doi: 10.1207/s15402010bsm0402_3.
Rush AJ, Kraemer HC, Sackeim HA, et al. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology. 2006;31:1841–53. doi: 10.1038/sj.npp.1301131.
Views:
24
Downloads:
8
Copyright (c) 2025 Aleksandra Anna Strzelecka, Aleksandra Ewa Basak, Sandra Khiralla-Gawlik, Agnieszka Kwiatkowska, Kinga Teper, Patrycja Świercz, Ewelina Mączka, Konrad Strużek, Wiktor Tracz
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
